Translator Disclaimer
1 November 2005 Preclinical Evaluation of a Novel Water-soluble Chlorin E6 Derivative (BLC 1010) as Photosensitizer for the Closure of the Neovessels
Author Affiliations +

In the present study, photodynamic activity of a novel photosensitizer (PS), Chlorin e6-2.5 N-methyl-d-glucamine (BLC 1010), was evaluated using the chorioallantoic membrane (CAM) as an in vivo model. After intravenous (i.v.) injection of BLC 1010 into the CAM vasculature, the applicability of this drug for photodynamic therapy (PDT) was assessed in terms of fluorescence pharmacokinetics, i.e. leakage from the CAM vessels, and photothrombic activity. The influence of different PDT parameters including drug and light doses on the photodynamic activity of BLC 1010 has been investigated. It was found that, irrespective of drug dose, an identical continuous decrease in fluorescence contrast between the drug inside and outside the blood vessels was observed. The optimal treatment conditions leading to desired vascular damage were obtained by varying drug and light doses. Indeed, observable damage was achieved when irradiation was performed at light doses up to 5 J/cm2 1 min after i.v. injection of drug doses up to 0.5 mg/kg body weight(b.w.). However, when irradiation with light doses of more than 10 J/cm2 was performed 1 min after injection of drug doses up to 2 mg/kg body weight, this led to occlusion of large blood vessels. It has been demonstrated that it is possible to obtain the desired vascular occlusion and stasis with BLC 1010 for different combinations of drug and/or light doses.

B. Pegaz, E. Debefve, F. Borle, J-P. Ballini, G. Wagnières, S. Spaniol, V. Albrecht, D. Scheglmann, N. E. Nifantiev, H. van den Bergh, and Y. N. Konan "Preclinical Evaluation of a Novel Water-soluble Chlorin E6 Derivative (BLC 1010) as Photosensitizer for the Closure of the Neovessels," Photochemistry and Photobiology 81(6), 1505-1510, (1 November 2005).
Received: 23 February 2005; Accepted: 1 June 2005; Published: 1 November 2005

This article is only available to subscribers.
It is not available for individual sale.

Get copyright permission
Back to Top